Detalhe da pesquisa
1.
Seladelpar combined with complementary therapies improves fibrosis, inflammation, and liver injury in a mouse model of nonalcoholic steatohepatitis.
Am J Physiol Gastrointest Liver Physiol
; 326(2): G120-G132, 2024 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38014444
2.
Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis.
Hepatology
; 2023 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38117036